Scheduled follow-up · Dec 31, 2026
Scheduled follow-up · Dec 31, 2026
Completion due · Dec 31, 2026
Scheduled follow-up · Dec 12, 2026
Scheduled follow-up · Dec 12, 2026
Scheduled follow-up · Nov 12, 2026
Scheduled follow-up · Nov 12, 2026
Scheduled follow-up · Oct 13, 2026
Scheduled follow-up · Oct 13, 2026
Scheduled follow-up · Sep 13, 2026
Scheduled follow-up · Sep 13, 2026
Scheduled follow-up · Aug 14, 2026
Scheduled follow-up · Aug 14, 2026
Scheduled follow-up · Jul 15, 2026
Scheduled follow-up · Jul 15, 2026
Scheduled follow-up · Jun 15, 2026
Scheduled follow-up · Jun 15, 2026
Scheduled follow-up · May 16, 2026
Scheduled follow-up · May 16, 2026
Scheduled follow-up · Apr 16, 2026
Scheduled follow-up · Apr 16, 2026
Scheduled follow-up · Mar 17, 2026
Scheduled follow-up · Mar 17, 2026
Scheduled follow-up · Feb 15, 2026
Scheduled follow-up · Feb 15, 2026
Update · Jan 17, 2026, 11:00 AMcomplete
The claim is that the TRICARE option period for Evernorth Federal Services TRICARE Pharmacy Benefit Program contract runs from Jan. 1, 2026, to Dec. 31, 2026. This refers to an exercised option year on Defense Health Agency contract HT940221C0007 for pharmacy benefit management.
An award record from EnvZone, which reproduces federal contract details, reports that Evernorth Federal Services Inc. was awarded $719,426,247 for the fourth option (of seven one-year option periods) on the TRICARE Pharmacy Benefit Program contract. It explicitly states that "the period of performance for this option is Jan. 1, 2026, to Dec. 31, 2026," matching the claimed dates.
Defense Daily, a defense-industry publication that posts contract announcements, likewise describes the same modification (P00093) on contract HT940221C0007. It notes that this fourth option year for TRICARE Pharmacy Benefit services has a period of performance from Jan. 1, 2026, through Dec. 31, 2026, confirming the timeframe.
GovCon Wires coverage of concurrent DHA TRICARE awards further corroborates the timing, stating that Evernorth was awarded about $719.4 million for the fourth option year of its TRICARE Pharmacy Benefit Program contract and that "the option year also covers Jan. 1 to Dec. 31, 2026." This independently aligns with the other contract-focused sources.
Although direct access to the Defense Departments own contract announcement page is blocked by an access-control error, the three independent sector sources are all quoting standard contract language and are consistent with each other. These outlets have incentives to accurately reproduce official award notices, since inaccuracies would undermine their value to government contractors and investors.
Given the concordant evidence from multiple contract-reporting sources, the specific option period for Evernorths TRICARE Pharmacy Benefit Program contract clearly runs from Jan. 1, 2026, through Dec. 31, 2026. The claim about the dates of the option period is therefore accurate and can be considered fully confirmed.
- EnvZone award record, 2025-12-15: Evernorth Federal Services awarded fourth option on TRICARE Pharmacy Benefit Program; period of performance Jan. 1, 2026 to Dec. 31, 2026 (https://envzone.com/award-record/evernorth-federal-wins-719m-option-for-tricare-pharmacy-benefit-program/)
- Defense Daily contract notice, 2025-12-17: Describes same $719,426,247 fourth option on contract HT940221C0007 with period of performance Jan. 1, 2026 to Dec. 31, 2026 (https://www.defensedaily.com/contract-awards/contract-award-evernorth-federal-services-inc-st-louis-missouri-719426247/)
- GovCon Wire, 2025-12-18: Article on DHA TRICARE awards notes Evernorths fourth option year for TRICARE Pharmacy Benefit Program "also covers Jan. 1 to Dec. 31, 2026" (https://www.govconwire.com/articles/dha-tricare-humana-evernorth-ipsos)
Scheduled follow-up · Jan 16, 2026
Scheduled follow-up · Jan 16, 2026overdue
Original article · Dec 17, 2025